TED_003 📄 Overview Augmented reality (AR) or smart glasses equipped with miniaturized optical sensors, accelerometers, and gyroscopes to continuously monitor key ocular biometrics relevant to TED. This includes precise measurement of proptosis, lid retraction, ocular motility (range and speed), pupillary responses, and potentially even subtle changes in ocular surface (via integrated micro-cameras). Data would be securely transmitted for AI-driven analysis and clinician review. Key technologies: 👤 Target users: 👍 Benefits Highly objective and continuous tracking of disease progression/regression • Early detection of subtle changes missed by episodic exams • Real-time assessment of treatment response • Personalized alerts for patients and clinicians • Deeper understanding of the diurnal variation and triggers of TED symptoms Use bullets or new lines. 👎 Challenges Miniaturization of sensors without compromising accuracy • Battery life and user comfort for continuous wear • Calibration and validation against gold-standard clinical measurements • Data overload for clinicians and effective visualization of trends • User acceptance and aesthetic considerations of smart eyewear 📋 Regulatory & Validation Likely Class II or III SaMD due to continuous monitoring and potential diagnostic claims. • Requires extensive clinical trials to prove accuracy, reliability, and clinical utility. • Strong emphasis on data security and privacy for highly sensitive biometric data.